The analyses mentioned above can be attributed to a predictable conclusion that, when the small-molecule inhibitor binds to the S protein, it substantially affects the binding to the ACE2 domain, which may be helpful to reduce the chances of the signal cascading process in host viral infection. Here, ACE2 is linked to viral infectious disease.